| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |